IFIH1 and dermatomyositis: Anti-MDA5 Ab-positive DM patients had a lower relapse rate during the 2 years after the initial treatment compared to other DM patients.[4,5] However, it has been only about 10 years since DM patients with anti-MDA5 antibody-positive were well recognized.